According to Benzinga Pro data, during Q4, Orthofix Medical (NASDAQ: OFIX ) posted sales of $122.23 million. Earnings were up 34.1%, but Orthofix Medical still reported an overall loss of $7.06 million. Orthofix Medical collected $114.00 million in revenue during Q3, but reported earnings showed a $10.72 million loss. What Is Return On Invested Capital? Earnings data without context is not clear and can difficult to base trading decisions on. Return on Invested Capital (ROIC) helps to filter signal from noise by measuring yearly pre-tax profit relative to invested capital by a business. Generally, a higher ROIC suggests successful growth of … Full story available on Benzinga.com

LEWISVILLE, Texas--(BUSINESS WIRE)--(NASDAQ:OFIX) The merger of Orthofix Medical Inc. ("Orthofix") and SeaSpine Holdings Corporation ("SeaSpine") became effective as of January 5, 2023. This news release includes the financial results of stand-alone Orthofix and stand-alone SeaSpine for the fourth quarter and full year ended December 31, 2022. As such, these financial results do not include any potential accounting adjustments the merger may have on future net sales or operating results. Orthof

Orthofix Medical (NASDAQ: OFIX ) is set to give its latest quarterly earnings report on Monday, 2023-03-06. Here''s what investors need to know before the announcement. Analysts estimate that Orthofix Medical will report an earnings per share (EPS) of $0.34. Orthofix Medical bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the … Full story available on Benzinga.com